Drug – bio-affecting and body treating compositions – Identification or warning feature – Taste or smell or chemical irritation to the eye – nose – or...
Patent
1989-04-17
1991-04-02
Goldberg, Jerome D.
Drug, bio-affecting and body treating compositions
Identification or warning feature
Taste or smell or chemical irritation to the eye, nose, or...
514 34, 514110, 514245, 424649, A61K 3171, A61K 3166, A61K 3153, A61K 3324
Patent
active
050045938
ABSTRACT:
A method is provided for reducing the side effects of chemotherapy with hexamethylmelamine (HMM) comprising intravelously administering a stabilized solution of HMM in an aqueous lipid dispersion, so that the central nervous system toxicity associated with oral HMM administration is reduced or eliminated.
REFERENCES:
patent: 32393 (1887-04-01), Wretlind et al.
patent: 4784845 (1988-11-01), Desai et al.
B. J. Foster et al., Cancer Treat. Rev., 13, 197-217 (1986).
J. Louis et al., Clin. Pharmacol. Therap., 8, 55-64 (1967).
M. D'Incalci et al., Cancer Treat. Rep., 62, 2117-2119 (1978).
M. M. Ames et al., Cancer Res., 39, 5016-5021 (1979).
M. M. Ames and J. S. Kovach, Cancer Treat. Rep., 66, 1579-1581 (1982).
M. M. Ames and J. S. Kovach, "A Parenteral Formulation of Hexamethylmelamine for Use in Cancer Patients," IUPHAR 9th International Congress of Pharmacology, London, England (abstract) (1984).
R. L. Richardson et al., Proc. Amer. Assoc. Cancer Res., 27, 167 (abstract No. 662) (1986).
A. B. Borkovec and A. B. DeMilo, "Insect Chemosterilants V. Derivatives of Melamine," J. Med. Chem., 10, 457-461 (1967).
S. S. Legha et al., Cancer, 38, 27-35 (1976).
M. M. Ames and G. Powis, J. Chromatogr., 174, 245-249 (1979).
M. M. Ames et al., Life Sciences, 29, 1591-1598 (1981).
M. M. Ames et al., Cancer Res., 43, 500-504 (1983).
R. H. Blum et al., Europ. J. Cancer, 9, 195-202 (1973).
K. J. Miller et al., Cancer Chemother. Pharmacol., 15, 49-53 (1985).
R. L. Richardson et al., Proc. Amer. Assoc. Cancer Res., 27, 166 (abstract) (1986).
Ames Matthew M.
Kovach John S.
Goldberg Jerome D.
Mayo Foundation for Medical Education and Research
LandOfFree
Hexamethylmelamine formulation exhibiting reduced neurotoxicity does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Hexamethylmelamine formulation exhibiting reduced neurotoxicity, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Hexamethylmelamine formulation exhibiting reduced neurotoxicity will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-325984